SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for the beneficial effects of polyphenols on hepatic lipid accumulation, hyperlipidemia, and atherosclerosis in type 1 diabetic mice, we hypothesize that polyphenol-activated SIRT1 acts upstream of AMPK signaling and hepatocellular lipid metabolism. Here we show that polyphenols, including resveratrol and the synthetic polyphenol S17834, increase SIRT1 deacetylase activity, LKB1 phosphorylation at Ser(428), and AMPK activity. Polyphenols substantially prevent the impairment in phosphorylation of AMPK and its downstream target, ACC (acetyl-CoA carboxylase), elevation in expression of FAS (fatty acid synthase), and lipid accumulation in human HepG2 hepatocytes exposed to high glucose. These effects of polyphenols are largely abolished by pharmacological and genetic inhibition of SIRT1, suggesting that the stimulation of AMPK and lipid-lowering effect of polyphenols depend on SIRT1 activity. Furthermore, adenoviral overexpression of SIRT1 stimulates the basal AMPK signaling in HepG2 cells and in the mouse liver. AMPK activation by SIRT1 also protects against FAS induction and lipid accumulation caused by high glucose. Moreover, LKB1, but not CaMKKbeta, is required for activation of AMPK by polyphenols and SIRT1. These findings suggest that SIRT1 functions as a novel upstream regulator for LKB1/AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism. Targeting SIRT1/LKB1/AMPK signaling by polyphenols may have potential therapeutic implications for dyslipidemia and accelerated atherosclerosis in diabetes and age-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SIRT1 crosstalks with the mTOR and AMPK pathways by interacting with hamartin–tuberin and deacetylating LKB1”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Cited by
Items 301–400 of 790
Morales-Alamo, D., Ponce-González, J. G., Guadalupe-Grau, A., Rodríguez-García, L., Santana, A., Cusso, R., Guerrero, M., Dorado, C., Guerra, B., & Calbet, J. A. L. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01246.2012 · Cited by 58
SIRT1: Role in cardiovascular biology
Ma, L., & Li, Y. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.036 · Cited by 64
“Resveratrol action on AMPK is SIRT1 dependent [100,101], others suggest that SIRT1 is dispensable for resveratrol-induced AMPK-activation [99,102].”
BackgroundMetformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
Kang, H. S., Cho, H., Lee, J., Oh, G. T., Koo, S., Park, B., Lee, I., Choi, H., Song, D., & Im, S. (2016) · Scientific Reports · doi:10.1038/srep23665 · Cited by 63
Shen, C., Dou, X., Ma, Y., Ma, W., Li, S., & Song, Z. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.03.005 · Cited by 63
“As nicotinamide is also the general product of SIRT1-catalyzed deacetylation reactions, high concentrations of nicotinamide has been generally used as a SIRT1 inhibitor [26-28].”
BackgroundXie, W., Ge, X., Li, L., Yao, A., Wang, X., Li, M., Gong, X., Chu, Z., Lu, Z., Huang, X., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0225-5 · Cited by 64
Hwang, K., Kim, H., Song, I.-S., Park, C., Jung, J. W., Park, D., Oh, S., Kim, Y.-S., & Kim, H.-R. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.50080 · Cited by 64
“They perform this role independently or cooperatively by coordinating with each other and sharing a common target molecule [36, 37].”
BackgroundQuercetin activates the Sestrin2/AMPK/SIRT1 axis to improve amyotrophic lateral sclerosis
Jin, T., Zhang, Y., Botchway, B. O. A., Huang, M., Lu, Q., & Liu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114515 · Cited by 64
Impaired Cardiac SIRT1 Activity by Carbonyl Stress Contributes to Aging-Related Ischemic Intolerance
Gu, C., Xing, Y., Jiang, L., Chen, M., Xu, M. G., Yin, Y., Li, C., Yang, Z., Yu, L., & Ma, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074050 · Cited by 60
“The nuclear-cytoplasmic fraction of heart tissue was conducted using the NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Thermo, Fisher Scientific, Rockford, IL, USA) [14].”
BackgroundMethodYang, Z., Wang, X., He, Y., Qi, L., Yu, L., Xue, B., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049935 · Cited by 61
“deacetylating and activating LKB1, the upstream kinase of AMPK [36,37].”
BackgroundAdjei‐Mosi, J., Sun, Q., Smithson, S. B., Shealy, G. L., Amerineni, K. D., Liang, Z., Chen, H., Wang, M., Ping, Q., Han, J., et al. (2023) · Aging Cell · doi:10.1111/acel.13811 · Cited by 62
Self-citationFan, L., Xu, H., Yang, R., Zang, Y., Chen, J., & Qin, H. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02191 · Cited by 62
Abdollahi, S., Salehi‐Abargouei, A., Toupchian, O., Sheikhha, M. H., Fallahzadeh, H., Rahmanian, M., Tabatabaie, M., & Mozaffari–Khosravi, H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6487 · Cited by 60
“It is also suggested that this compound induces lipid‐ lowering effects through SIRT1‐AMPK axis by stimulation of AMPK phosphorylation and SIRT1 activation, resulting in inhibition of fatty acid synthesis (Alberdi et al., 2013; Hou et al., 2008; Kang et al., 2012).”
BackgroundPotential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arabshomali, A., Bazzazzadehgan, S., Mahdi, F., & Shariat‐Madar, Z. (2023) · Molecules · doi:10.3390/molecules28207209 · Cited by 69
“In addition, SIRT1 regulates hepatic lipid metabolism by increasing AMP-activated protein kinase, leading to the inhibition of hepatic lipogenic pathways in favor of fatty acid oxidation [153].”
BackgroundExendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism
Lee, J., Hong, S.-W., Park, S. E., Rhee, E.-J., Park, C.-Y., Oh, K.-W., Park, S.-W., & Lee, W.-Y. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0490-3 · Cited by 56
“SIRT1 is an upstream factor of AMPK in hepatocytes, but not in skeletal muscle (Lee et al. 2012; Hou et al. 2008; Canto et al. 2009).”
BackgroundIp, B. C., Chun, L., Lichtenstein, A. H., Lintig, J. V., & Wang, X.-D. (2014) · Journal of Nutrition · doi:10.3945/jn.114.200238 · Cited by 62
“The following antibodies were used for western blotting: acetyl-CoA carboxylase (ACC), AMPactivated protein kinase (AMPK) a, phosphorylated-ACC (Ser79), phosphorylated-AMPKa (Thr172), stearoyl-CoA desaturase (SCD1) (Cell Signaling), IL-6 (R&D), acetylated-Foxhead box protein O1 (FoxO1), heme-oxygenase (HO)-1, and sirt…”
BackgroundInfluentialGlutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1
Shao, D., Han, J., Hou, X., Fry, J., Behring, J. B., Seta, F., Long, M. T., Roy, H. K., Cohen, R. A., Matsui, R., et al. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6716 · Cited by 55
“Activation or overexpression of SirT1 can alleviate diet-induced NAFL (35, 46, 56) through downregulation of SREBP1 (56).”
BackgroundSelf-citationKaramzad, N., Maleki, V., Carson‐Chahhoud, K., Azizi, S., Sahebkar, A., & Gargari, B. P. (2019) · BioFactors · doi:10.1002/biof.1569 · Cited by 57
“Activation of AMPK has been found to regulate glucose hemostasis and insulin sensitivity in different ways, such as through regulation of cellular lipid metabolism through stimulation of β-oxidation in fatty acids.(68) It also activates IRS by tyrosine phosphorylation and activates the PI3K pathway improving the insul…”
BackgroundChen, X., Shang, L., Deng, S., Li, P., Chen, K., Gao, T., Zhang, X., Chen, Z., & Zeng, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013583 · Cited by 56
“SIRT1 and AMPK are known fuel-sensingmolecules, and activation of the SIRT1/AMPKpathway plays a central role in regulating hepatic fatty acid metabolism (39).”
BackgroundInfluentialNonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Huang, Y. Y., Gusdon, A. M., & Qu, S. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-171 · Cited by 60
“acts as a metabolic regulatory through its ability to sense NAD+ levels and also is an upstream regulator of AMPK [65].”
BackgroundArunima, S., & Rajamohan, T. (2014) · British Journal of Nutrition · doi:10.1017/s000711451400004x · Cited by 55
SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
Yu, L., Liu, X., Yuan, Z., Li, X., Yang, H., Yuan, Z., Sun, L., Zhang, L., & Jiang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00256 · Cited by 57
“SIRT1 regulates various nuclear receptors and cofactors directly or indirectly, such as FXR, HNF1α, LXR, E2F1, p53, PGC-1α, and HSF1 (Gerhart-Hines et al., 2007; Hou et al., 2008; Ponugoti et al., 2010).”
BackgroundGinkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells
Huang, W., Chen, Y.-L., Liu, H.-C., Wu, S., & Liou, C. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.07.006 · Cited by 59
“Interestingly, ACC phosphorylation reduces the synthesis of malonyl-CoA and the extension and synthesis of the fatty acid chain (Hou et al., 2008).”
Momtaz, S., Maghsoudi, A. S., Abdolghaffari, A. H., Jasemi, E., Rezazadeh, S., Hassani, S., Ziaee, M., Abdollahi, M. R., Behzad, S., & Nabavi, S. M. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1648376 · Cited by 57
“combretastatin A-4) activated AMPK/SIRT1 in diabetic mice [101,102].”
BackgroundOsawa, Y., Seki, E., Kodama, Y., Suetsugu, A., Miura, K., Adachi, M., Ito, H., Shiratori, Y., Banno, Y., Olefsky, J. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-168351 · Cited by 62
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Sharma, M., Premkumar, M., Kulkarni, A. V., Kumar, P., Reddy, D. N., & Rao, N. P. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00055 · Cited by 61
“[121] Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, et al.”
BackgroundThe sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism
Fiorino, E., Giudici, M., Ferrari, A., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2014) · IUBMB Life · doi:10.1002/iub.1246 · Cited by 63
“It activates the AMPK/LKB1 signaling pathway leading to increased fatty acid oxidation and preventing lipogenic pathways (56).”
BackgroundBanerjee, K. K., Ayyub, C., Sengupta, S., & Kolthur‐Seetharam, U. (2012) · Aging · doi:10.18632/aging.100435 · Cited by 58
“Importantly, from our results, and studies on mammalian SIRT1 [29, 33, 58] an evolutionarily conserved role for Sir2 (dSir2/SIRT1) in regulating fat metabolism becomes obvious.”
BackgroundBansode, R. R., Randolph, P. D., Ahmedna, M., Hurley, S. L., Hanner, T. L., Baxter, S. A., Johnston, T. A., Su, M., Holmes, B. M., Yu, J., et al. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.09.129 · Cited by 54
Sid, V., Wu, N., Sarna, L. K., Siow, Y. L., House, J. D., & Karmin, O. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00260.2015 · Cited by 61
“HepG2 cells resemble many characteristics of hepatocytes and have been used as a valuable cell model in metabolic studies, including regulation of AMPK (22).”
BackgroundMethodInfluentialHuang, W., Liao, P.-C., Huang, C., Hu, S., Huang, S.-C., & Wu, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.051 · Cited by 55
Grape seed procyanidin B2 ameliorates hepatic lipid metabolism disorders in db/db mice
Yin, M., Zhang, P., Yu, F., Zhang, Z., Cai, Q., Lu, W., Li, B., Qin, W., Cheng, M., Wang, H., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6900 · Cited by 56
“A previous study demonstrated that dysfunction of hepatic AMPK in diabetes represents a key mechanism for hepatic lipid accumulation and hyperlipidemia associated with diabetes (8).”
Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells
Yuan, W., Fang, W., Zhang, R., Lyu, H., Xiao, S., Guo, D. S., Ali, D. W., Michalak, M., Chen, X., Zhou, C., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119537 · Cited by 57
Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells
Weikel, K. A., Cacicedo, J. M., Ruderman, N. B., & Ido, Y. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00265.2014 · Cited by 53
Self-citationSeo, K., Seo, S., Han, J. Y., Ki, S. H., & Shin, S. M. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.011 · Cited by 58
Effects of exercise training and resveratrol on vascular health in aging
Gliemann, L., Nyberg, M., & Hellsten, Y. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.037 · Cited by 56
Hwang, Y. P., Kim, H. G., Choi, J. H., Truong, M., Chung, Y., Jeong, T. C., & Jeong, H. G. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.006 · Cited by 57
“Additionally, SIRT1 is involved in regulating lipid metabolism through AMPK activation [44].”
BackgroundExendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis
Lee, J., Hong, S., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S. W., & Lee, W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.011 · Cited by 53
Li, J., Dou, X., Li, S., Zhang, X., Zeng, Y., & Song, Z. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.003 · Cited by 52
“It is the general product of Sirt1catalyzed deacetylation reactions and was reported to inhibit Sirt1 enzyme activity with either competitive or noncompetitive mechanism [27-29].”
BackgroundDong, W., Wang, X., Bi, S., Pan, Z., Liu, S.-X., Yu, H., LU, H., Lin, X., WANG, X., MA, T., et al. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1680 · Cited by 51
Rebollo, A., Roglans, N., Baena, M., Sánchez, R. M., Merlos, M., Alegret, M., & Laguna, J. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.002 · Cited by 53
“Activation of AMPK [33], which we can rule out”
BackgroundIn Vivo RNA Interference Models of Inducible and Reversible Sirt1 Knockdown in Kidney Cells
Chuang, P. Y., Xu, J., Dai, Y., Jia, F., Mallipattu, S. K., Yacoub, R., Gu, L., Premsrirut, P. K., & He, J. C. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.016 · Cited by 50
mTOR: more targets of resveratrol?
Widlund, A. L., Baur, J. A., & Vang, O. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.11 · Cited by 52
Rao, Y., Yu, H., Gao, L., Lu, Y., Zhao, X. D., Liu, H., Gu, L., Ye, J., & Huang, Z. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13855 · Cited by 51
“Bou stimulates the AMPK signalling pathway via the SIRT1–LKB1 complex It has been suggested that deacetylation of LKB1 by SIRT1 promotes the phosphorylation of AMPK via facilitating the translocation of LKB1 from the nucleus to the cytosol (Hou et al., 2008; Yang et al., 2014).”
BackgroundSignaling Network of Forkhead Family of Transcription Factors (FOXO) in Dietary Restriction
Jiang, Y.-Z., Yan, F., Feng, Z., Lazarovici, P., & Zheng, W. (2019) · Cells · doi:10.3390/cells9010100 · Cited by 56
Vera, I., Gómez-de-Regil, L., Solis, A. L. G., Lugo, R., Guevara‐Cruz, M., Pedraza‐Chaverrí, J., & Ávila-Nava, A. (2021) · Antioxidants · doi:10.3390/antiox10020225 · Cited by 54
“The activation of AMPK in a SIRT1-dependent fashion, in turns inhibits enzymatic activity of FAS, which is key downstream regulators of AMPK in the control of lipid metabolism, it reduces lipid accumulation, and increased fatty acid oxidation and/or decreased fatty acid synthesis [39].”
BackgroundCullberg, K. B., Ølholm, J., Paulsen, S. K., Foldager, C. B., Lind, M., Richelsen, B., & Pedersen, S. B. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.014 · Cited by 52
Zhang, Y., Qian, Q., Ge, D., Li, Y., Wang, X., Chen, Q., Gao, X., & Wang, T. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2028494 · Cited by 54
Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells
Jung, Y. R., Kim, E. J., Choi, H. J., Park, J.-J., Kim, H.-S., Lee, Y., Park, M., & Lee, M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098616 · Cited by 50
“Notably, LKB1 has been identified as a substrate of SIRT1 deacetylase (Hou et al., 2008).”
BackgroundMaissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 48
Alpha-lipoic Acid: An Antioxidant with Anti-aging Properties for Disease Therapy
Shanaida, M., Lysiuk, R., Мykhailenko, O., Hudz, N., Abdulsalam, A., Гонтова, Т. М., Oleshchuk, O., Ivankiv, Y. I., Shanaida, V., Литкін, Д. В., et al. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673300496240416114827 · Cited by 55
Fu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.006 · Cited by 51
Henriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 52
“This finding is consistent with previous reports on the effects of AMPK activation on fat accumulation in the liver [45-47].”
Resultda Silva, R. C., Batista, A., da Costa, D. C. F., Moura‐Nunes, N., Koury, J. C., da Costa, C. A., Resende, Â. C., & Daleprane, J. B. (2018) · Food Research International · doi:10.1016/j.foodres.2018.05.043 · Cited by 49
Zhu, X., Guo, X., Mao, G., Gao, Z., Wang, H., He, Q., & Li, D.-D. (2012) · Phytotherapy Research · doi:10.1002/ptr.4728 · Cited by 51
“In addition, recent studies indicated that SIRT1 has a vital role in liver biology (Hou et al., 2008; Jin et al., 2011; Pfluger et al., 2008).”
BackgroundHwang, Y. P., Choi, J. H., Kim, H. G., Khanal, T., Song, G., Nam, M. S., Lee, H.-S., Chung, Y., Lee, Y. C., & Jeong, H. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.001 · Cited by 51
“Emerging evidence suggests that SIRT1 cooperates with AMPKα to regulate energy metabolism (Hou et al., 2008).”
BackgroundMa, Y., Fuzhen, Y., Wang, Y., Du, Z., Liu, D.-H., Guo, H., Shen, J., & Peng, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047900 · Cited by 54
“A number of studies demonstrate that LKB1 may act as an upstream kinase responsible for resveratrol- and theaflavins-induced AMPK activation [5,18,19].”
BackgroundResveratrol as a novel treatment for diseases with mTOR pathway hyperactivation
Alayev, A., Berger, S. M., & Holz, M. K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12829 · Cited by 49
Carey, A. L., & Kingwell, B. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1420-x · Cited by 53
“In addition, resveratrol also activates AMPK in cell culture systems, although not via direct interaction [71].”
BackgroundThe protective effect of resveratrol against cytotoxicity induced by mycotoxin, zearalenone
Sang, Y., Li, W., & Zhang, G. (2016) · Food & Function · doi:10.1039/c6fo00191b · Cited by 50
He, M., Tan, B., Vasan, K., Yuan, H., Cheng, F., da Silva, S. R., Lu, C., & Gao, S. (2017) · The Journal of Pathology · doi:10.1002/path.4905 · Cited by 52
“AMPK activation by resveratrol required both SIRT1 and LKB1, and resveratrol increased LKB1 phosphorylation at serine 428 (Ser428) [33,34].”
BackgroundRetinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1
Geng, C., Xu, H. C., Zhang, Y., Gao, Y., Li, M., Liu, X., Gao, M., Wang, X., Liu, X., Fang, F., et al. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9027-6 · Cited by 49
Hesperetin is a potent bioactivator that activates SIRT1-AMPK signaling pathway in HepG2 cells
Afra, H. S., Zangooei, M., Meshkani, R., Ghahremani, M. H., Ilbeigi, D., Khedri, A., Shahmohamadnejad, S., Khaghani, S., & Nourbakhsh, M. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00678-4 · Cited by 49
Aoun, M., Michel, F., Fouret, G., Casas, F., Jullien, M., Wrutniak‐Cabello, C., Ramos, J., Cristol, J., Coudray, C., Carbonneau, M., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002850 · Cited by 52
“Different reports((15,16)) showed that elevated glucose inhibited AMP kinase activity and acetyl-CoA carboxylase phosphorylation and thus increased hepatocellular lipid accumulation.”
BackgroundResultInfluentialPeng, Y., Rideout, D. A., Rakita, S., Gower, W. R., You, M., & Murr, M. M. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1102-5 · Cited by 50
Choi, Y., Suh, H.-R., Yoon, Y., Lee, K. J., Kim, D. G., Kim, S., & Lee, B. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0347-z · Cited by 50
“Increased SIRT1 activity by resveratrol stimulates AMPK through LKB1 and protects against lipid accumulation through enhanced FAS expression (Hou et al. 2008).”
BackgroundCross Regulation of Sirtuin 1, AMPK, and PPARγ in Conjugated Linoleic Acid Treated Adipocytes
Jiang, S., Wang, W., Miner, J., & Fromm, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048874 · Cited by 42
“SIRT1 deacetylates liver kinase B1 (LKB1), facilitating the ability of LKB1 to phosphorylate AMPK, defining a SIRT1/ LKB1/AMPK signaling pathway that provides one of the connections between SIRT1 and AMPK for regulating energy metabolism [36,37].”
Vazirian, M., Nabavi, S. M., Jafari, S., & Manayi, A. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.079 · Cited by 48
Podocyte Autophagy in Homeostasis and Disease
Lin, Q., Banu, K., Ni, Z., Leventhal, J. S., & Menon, M. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061184 · Cited by 52
“Furthermore, SIRT1 can also trigger LKB1 deacetylation activating AMPK to maintain energy metabolism, cell survival, and autophagy [31,32].”
BackgroundHsu, M., Savas, Ü., Lasker, J. M., & Johnson, E. F. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175851 · Cited by 46
“Resveratrol (Hou et al., 2008) has been reported to activate AMPK indirectly.”
BackgroundInfluentialParra-Vargas, M., Sandoval-Rodriguez, A. S., Rodriguez‐Echevarría, R., Domínguez-Rosales, J. A., Santos, A., & Armendáriz‐Borunda, J. (2018) · Nutrients · doi:10.3390/nu10081060 · Cited by 47
“The activation of sirtuin 1 (SIRT1) by other polyphenols promoted AMPK activation in an LKB1-dependent mechanism [30].”
BackgroundTain, Y., Jheng, L., Chang, S. K. C., Chen, Y., Huang, L., Liao, J.-X., & Hou, C. (2020) · Molecules · doi:10.3390/molecules25184199 · Cited by 46
“Figure 6C shows that 50 μM of RE inhibited fat accumulation during Nile red staining and DAPI staining, and these results are similar to the results obtained in a previous study [36].”
ResultAMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability
Yang, Y. M., Han, C. Y., Kim, Y. J., & Kim, S. G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i30.3731 · Cited by 50
Ido, Y., Duranton, A., Lan, F., Cacicedo, J. M., Chen, T. C., Breton, L., & Ruderman, N. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035092 · Cited by 43
“AICAR, a widely used AMPK activator, and resveratrol, a putative direct activator of both AMPK and SIRT1 [32] were used.”
MethodSelf-citationWhite, A. T., McCurdy, C. E., Philp, A., Hamilton, D. L., Johnson, C. D., & Schenk, S. (2013) · Diabetologia · doi:10.1007/s00125-013-2912-2 · Cited by 50
“SIRT1 has been proposed to be an important regulator of AMPK activity through its ability to regulate liver kinase B1 [26–28], while other studies have demonstrated AMPK to be an important regulator of SIRT1 [29, 30].”
Cheng, J., Liu, C., Hu, K., Greenberg, A. S., Wu, D., Ausman, L. M., McBurney, M. W., & Wang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.004 · Cited by 47
Trepiana, J., Milton‐Laskibar, I., Gómez‐Zorita, S., Eseberri, I., González, M. A., Fernández‐Quintela, A., & Portillo, M. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113473 · Cited by 49
“In this regard, while some authors have reported that SIRT1 activates AMPK through the deacetylation of liver kinase B1 (LKB1, Figure 2) [18,19], other authors have suggested that AMPK activation results in an increased NAD+/NADH ratio, and thus, in greater SIRT1 activation [16,20].”
BackgroundMethodXia, X., Wang, X., Wang, H., Lin, Z., Shao, K., Xu, J., & Zhao, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113919 · Cited by 44
Vetterli, L., & Maechler, P. (2011) · Aging · doi:10.18632/aging.100304 · Cited by 51
“cytes [19], upstream in muscle cells [23, 24], and independent of SIRT1 in neurons [20].”
BackgroundNakatsu, Y., Iwashita, M., Sakoda, H., Ono, H., Nagata, K., Matsunaga, Y., Fukushima, T., Fujishiro, M., Kushiyama, A., Kamata, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658559 · Cited by 47
“AMPK activation reportedly induces mitochondria-related genes via coordination with Sirt1 in muscle (35, 50, 51).”
BackgroundIn Search of New Therapeutic Targets in Obesity Treatment: Sirtuins
Kurylowicz, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040572 · Cited by 42
“Activation of SIRT1 in the liver also induces phosphorylation of AMP-activated protein kinase (AMPK), which protects against fatty acid synthase induction and lipid accumulation caused by high glucose [25].”
BackgroundNa, A., Yang, E. J., Jeon, J. M., Ki, S. H., Song, K., & Lee, S. (2018) · Toxicological Research · doi:10.5487/tr.2018.34.1.023 · Cited by 43
“Studies in cultured hepatic cells have provided evidence that SIRT1 is able to stimulate AMPK activity via modulation of liver kinase B1, an upstream AMPK kinase (12,29).”
Santis, S. D., Clodoveo, M. L., Cariello, M., D’Amato, G., Franchini, C., Faienza, M. F., & Corbo, F. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1765736 · Cited by 49
“On the other hand, resveratrol could induces SIRT1 leading to AMPK activation via deacetylation of the AMPK kinase LKB1 (Hou et al. 2008; Ivanov et al. 2008; Lan et al. 2008).”
BackgroundEpigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
Claveria-Cabello, A., Colyn, L., Arechederra, M., Urman, J. M., Berasain, C., Avila, M. A., & Fernandez-Barrena, M. G. (2020) · Cells · doi:10.3390/cells9102321 · Cited by 43
Bogachus, L. D., & Turcotte, L. P. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00279.2010 · Cited by 51
“Although some studies conclude that AMPK activation stimulates SIRT1 possibly via a rise in intracellular NAD (10, 11, 13), others have suggested that SIRT1 increases AMPK activity possibly via changes in the acetylation state of LKB1 (30, 40).”
BackgroundInfluentialEnergy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
Yang, J., Nishihara, R., Zhang, X., Ogino, S., & Qian, Z. R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.012 · Cited by 44
“Besides, increased level of NAD+ because of high glucose or lipids will inhibit SIRT1 pathway which also contributes to the activation of mTORC pathway and the inhibition of autophagy pathway [81].”
BackgroundDo, D. N., Schenkel, F. S., Miglior, F., Zhao, X., & Ibeagha-Awemu, E. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31427-0 · Cited by 45
Hu, L., Chen, Y., Martínez-Cortés, I., Coleman, D. N., Dai, H., Liang, Y., Parys, C., Fernández, C., Wang, M., & Loor, J. J. (2020) · Food & Function · doi:10.1039/c9fo02379h · Cited by 46
Chalasani, N., Vuppalanchi, R., Rinella, M., Middleton, M. S., Siddiqui, M. S., Barritt, A. S., Kolterman, O., Flores, O., Alonso, C., Iruarrizaga‐Lejarreta, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14674 · Cited by 40
Pham, T. H., Lee, G. H., Jin, S. W., Lee, S. Y., Han, E. H., Kim, N. D., & Jeong, H. G. (2022) · Phytotherapy Research · doi:10.1002/ptr.7526 · Cited by 43
Tang, L., Chen, Y., Rui, B. B., & Hu, C. M. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0125 · Cited by 41
Kong, Q. Q., Zhang, H., Zhao, T., Zhang, W., Yan, M., Dong, X., & Li, P. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2799 · Cited by 41
“…and stearoyl CoA desaturase 1 (SCD1) (7,8) Studies have shown that silent mating type information regulation 2 homolog 1 (Sirt1) plays a central role in modulating hepatic fatty acid metabolism through AMPK and SREBP1, that is a critical mediator of fatty acid combustion and synthesis (9,10).”
Reyer, H., Oster, M., Magowan, E. A., Dannenberger, D., Ponsuksili, S., & Wimmers, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081674 · Cited by 40
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease
Yu, J., Peng, J., Luan, Z., Zheng, F., & Su, W. (2019) · Molecules · doi:10.3390/molecules24020230 · Cited by 41
“SIRT1 is an activator of Adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) pathway which inhibits hepatocyte lipid accumulation [93].”
BackgroundPittala, S., Krelin, Y., Kuperman, Y., & Shoshan‐Barmatz, V. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.06.017 · Cited by 42
“SIRT1 activity is linked with metabolic homeostasis through its ability to deacetylate target pro- 1858 Molecular Therapy Vol. 27 No 10 October 2019 teins.27 In response to low nutritional availability, SIRT1 functions as a master switch to maintain lipid and glucose homeostasis, insulin secretion, and energy balance…”
BackgroundResistant dextrin improves high-fat-high-fructose diet induced insulin resistance
Hu, F., Niu, Y., Xu, X., Hu, Q., Su, Q., & Zhang, H. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00450-2 · Cited by 43
“It has been reported that Sirt1 can stimulate the activation of AMPK, accelerating the decomposition of lipid to reducing liver fat accumulation [20].”
BackgroundHistone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases
Wang, F., & Chen, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.537519 · Cited by 43
MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1
McCubbrey, A. L., Nelson, J. D., Stolberg, V. R., Blakely, P. K., McCloskey, L., Janssen, W. J., Freeman, C. M., & Curtis, J. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1401838 · Cited by 40
Ebaid, G. M. X., Seiva, F. R. F., Rocha, K. K. H. R., Souza, G. A., & Novelli, E. L. B. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-46 · Cited by 42
“Olive oil and its compounds modulating cellular signal [39] and the activity of peptidases [3,40] would allow the adequate balance between uptake and metabolism of dietary compounds.”
BackgroundZhou, Y., Zhong, L., Yu, S., Shen, W., Cai, C., & Yu, H. (2020) · Aging · doi:10.18632/aging.103082 · Cited by 42
Shirane, A., Wada‐Hiraike, O., Tanikawa, M., Seiki, T., Hiraike, H., Miyamoto, Y., Sone, K., Hirano, M., Oishi, H., Oda, K., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.160 · Cited by 40
Metadata
- Authors
- Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., Cohen, R. A., & Zang, M.
- Affiliations
- Boston University (US)
- Institut de Recherches Internationales Servier (France) (FR)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 283
- Issue
- 29
- Pages
- 20015-20026
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2459285
- OpenAlex
- W1973163466
- Cited by
- 778
- References
- 57
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 26 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 38 · 2019: 42 · 2018: 52 · 2017: 49 · 2016: 50 · 2015: 50 · 2014: 60 · 2013: 71 · 2012: 54
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4458 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Servier
- National Institutes of Health (P01 HL 68758)
- Institut de Recherches Servier
- National Institute on Aging (R01 AG-27080, R01AG027080)
- National Heart, Lung, and Blood Institute (P01HL068758, P01-HL68758)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 76942, R01DK076942)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- SIRT1, AMPK, LKB1, polyphenols, resveratrol, hepatocyte lipid metabolism, hepatic lipid accumulation, fatty acid synthase, acetyl-CoA carboxylase, high glucose, dyslipidemia, atherosclerosis, type 1 diabetes, CaMKKβ
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Cell Line, Enzyme Activation, Flavonoids, Glucose, Humans, Multienzyme Complexes, Phenols, Signal Transduction, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Hepatocytes, RNA Interference, Sirtuins, Lipid Metabolism, Mice, Focal Adhesion Protein-Tyrosine Kinases, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases, Sirtuin 1, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.